We are live on ! Find out more
SGNT

SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT

Delisted

SGNT was delisted on the 29th of August, 2016.

131 hedge funds and large institutions have $614M invested in SAGENT PHARMACEUTICALS INC COM STK (DE) in 2014 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 57 increasing their positions, 30 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 30 | Existing positions closed: 10

90% more repeat investments, than reductions

Existing positions increased: 57 | Existing positions reduced: 30

15% more funds holding

Funds holding: 114131 (+17)

16% less capital invested

Capital invested by funds: $734M → $614M (-$119M)

100% less call options, than puts

Call options by funds: $4K | Put options by funds: $1.26M

Holders
131
Holders Change
+17
Holders Change %
+14.91%
% of All Funds
3.49%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
30
Increased
57
Reduced
30
Closed
10
Calls
$4K
Puts
$1.26M
Net Calls
-$1.25M
Net Calls Change
-$1.25M
Name Holding Trade Value Shares
Change
Change in
Stake
Thrivent Financial for Lutherans
51
Thrivent Financial for Lutherans
Minnesota
$1.27M +$1.25M +42,500 +521%
Ohio Public Employees Retirement System (OPERS)
52
Ohio Public Employees Retirement System (OPERS)
Ohio
$1.19M -$591K -20,139 -30%
Comerica Bank
53
Comerica Bank
Texas
$1.1M +$636K +21,664 +97%
FLAM
54
First Light Asset Management
Minnesota
$1.08M -$806K -27,461 -39%
Public Sector Pension Investment Board (PSP Investments)
55
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$1.07M
CIP
56
Convergence Investment Partners
Florida
$1.05M +$1.22M +41,750 New
DCM
57
Dupont Capital Management
Delaware
$1.04M +$1.21M +41,400 New
California State Teachers Retirement System (CalSTRS)
58
California State Teachers Retirement System (CalSTRS)
California
$1.02M +$5.08K +173 +0.4%
ARTA
59
A.R.T. Advisors
New York
$955K +$1.12M +38,044 New
AllianceBernstein
60
AllianceBernstein
Tennessee
$874K
SO
61
STRS Ohio
Ohio
$748K +$874K +29,800 New
Jacobs Levy Equity Management
62
Jacobs Levy Equity Management
New Jersey
$739K +$864K +29,450 New
AA
63
AlphaMark Advisors
Kentucky
$687K +$802K +27,350 New
PNC Financial Services Group
64
PNC Financial Services Group
Pennsylvania
$681K +$793K +27,029 +38,613%
Tudor Investment Corp
65
Tudor Investment Corp
Connecticut
$675K +$417K +14,200 +112%
ProShare Advisors
66
ProShare Advisors
Maryland
$663K +$20.6K +702 +3%
BG
67
BlackRock Group
United Kingdom
$656K +$429K +14,631 +127%
HW
68
Hancock Whitney
Mississippi
$642K +$241K +8,225 +47%
KBC Group
69
KBC Group
Belgium
$641K +$748K +25,508 New
PAMU
70
Pictet Asset Management (UK)
United Kingdom
$568K -$23.5K -800 -3%
GA
71
Geneva Advisors
Illinois
$559K
RhumbLine Advisers
72
RhumbLine Advisers
Massachusetts
$551K -$3.67K -125 -0.6%
AI
73
Analytic Investors
California
$543K -$61K -2,080 -9%
Susquehanna International Group
74
Susquehanna International Group
Pennsylvania
$537K +$628K +21,400 New
MAA
75
Managed Account Advisors
New Jersey
$523K -$99K -3,374 -14%

SGNT Hedge Fund Activity: Q4 2014 in Review

131 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) for Q4 2014, worth a combined $614M — down 16% from $734M a quarter earlier.

Buyers outnumbered sellers: 30 funds opened new SGNT positions and 10 closed out — a net gain of 20 holders — while 57 added to existing stakes and 30 trimmed.

The largest buyer was Acadian Asset Management, adding an estimated $19.4M. The largest seller was Franklin Resources, cutting an estimated $37.4M.

  • 131 institutional investors held SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) as of Q4 2014, up from 114 in Q3 2014.
  • Funds reported $614M of SAGENT PHARMACEUTICALS INC COM STK (DE) stock for Q4 2014, down 16% quarter-over-quarter.
  • 30 funds opened new SAGENT PHARMACEUTICALS INC COM STK (DE) positions in Q4 2014 and 10 closed out, a net change of +20 holders.
  • The largest SAGENT PHARMACEUTICALS INC COM STK (DE) buyer in Q4 2014 was Acadian Asset Management, an estimated $19.4M added.
  • The largest SAGENT PHARMACEUTICALS INC COM STK (DE) seller in Q4 2014 was Franklin Resources, an estimated $37.4M sold.

Based on aggregated 13F filings for Q4 2014.